Skip to main content
SpringerLink
Log in

Stem cells

HSCT for Crohn's disease: work in progress or a bridge too far?

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Haematopoietic stem cell transplantation for refractory Crohn's disease has the potential to halt therapy-resistant inflammation. Hawkey et al. argue that HSCT does not offer sustained benefit based upon their recent study; however, their study was designed using suboptimal end points and patients were not offered post-transplantation Crohn's disease medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hawkey, C. J. et al. Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial. JAMA 314, 2524–2534 (2015).

    Article  CAS  PubMed  Google Scholar 

  2. Duijvestein, M., van den Brink, G. R. & Hommes, D. W. Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J. Crohns Colitis 2, 99–106 (2008).

    Article  CAS  PubMed  Google Scholar 

  3. Burt, R. K. et al. Risks of immune system treatments. Science 328, 825–826 (2010).

    Article  CAS  PubMed  Google Scholar 

  4. Muraro, P. A. et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J. Exp. Med. 201, 805–816 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhang, L. et al. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-β-producing CD8+ Treg cells are associated with immunological remission of lupus. J. Immunol. 183, 6346–6358 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Burt, R. K. et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 116, 6123–6132 (2010).

    Article  CAS  PubMed  Google Scholar 

  7. D'Haens, G. et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371, 660–667 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Wolters, F. L. et al. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 55, 510–518 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lichtenstein, G. R. et al. Serious infections and mortality in associations with therapies for Crohn's disease: TREAT registry. Clin. Gastroent. Hepatol. 4, 621–630 (2006).

    Article  CAS  Google Scholar 

  10. Farge, D. et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group For Blood And Marrow Transplantation Working Party On Autoimmune Diseases. Haematologica 95, 284–292 (2010).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Digestive Diseases, Daniel W. Hommes and Precious N. Lacey are at the UCLA Center for Inflammatory Bowel Diseases, 10945 Le Conte Avenue #2338E, Los Angeles, California 90095, USA.,

    Daniel W. Hommes & Precious N. Lacey

Authors
  1. Daniel W. Hommes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Precious N. Lacey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel W. Hommes.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hommes, D., Lacey, P. HSCT for Crohn's disease: work in progress or a bridge too far?. Nat Rev Gastroenterol Hepatol 13, 128–130 (2016). https://doi.org/10.1038/nrgastro.2016.22

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2016.22

  • Springer Nature Limited

This article is cited by

Search

Navigation